Javascript must be enabled to continue!
ApoE4 accelerates the condensate to amyloid transition of tau
View through CrossRef
Abstract
Aberrant liquid to solid transition (LST) of tau is a pathological hallmark of several tauopathies, most notably Alzheimer’s disease (AD). ApoE4 is a major genetic risk factor for AD and has been shown to exacerbatetau pathology, although the underlying mechanismremains unclear. Herewe investigate whether apoE isoforms can influenceamyloid aggregation of tau occurring via the liquid–liquid phase separation (LLPS) pathway by monitoring individual tau condensates in real time using total internal reflection fluorescence microscopy (TIRFM) and confocal microscopy. We find that interaction of apoE with tau condensates is dependent on the lipidation status of apoE. Lipid-free apoE, even at 1:1000 substoichiometric concentrations, arrests growth but promotes ageing of the liquid condensates of tau. The strong effect of apoE is accompanied by its preferential accumulation inside the condensates, lowering of the surface tension and promoting amyloid nucleation. Lipidation of apoE2 and apoE3 diminished its amyloid promoting effects very strongly. However, apoE4 even in the lipidated forms accelerated the liquid to amyloid conversion of the tau condensates considerably. Furthermore, the amyloidogenic effect of apoE4 is correlated with its higher delipidation tendency compared to apoE2 and apoE3. Together, our study suggests that lipid-free apoE promotes tau aggregation via dual mechanisms by increasing condensate surface to volume ratio and by facilitating amyloid nucleation possibly at the condensate interfaces. We hypothesize that enhancing apoE4 lipidation in vivo presents a potential strategy to counteract its pathogenic effects on tau aggregation.
Highlights
All three lipid-free apoE isoforms strongly affect LLPS of tau even at a sub-stoichiometric (1:1000) ratio.
ApoE lowers the surface tension, reduces the size and increases the number of the condensates.
ApoE isoforms accelerate LST of the tau condensates.
Lipidation reduces the effects of apoE, strongly in apoE2 and apoE3 but less so in apoE4.
ApoE4 undergoes spontaneous delipidation faster than apoE3 and apoE2.
Title: ApoE4 accelerates the condensate to amyloid transition of tau
Description:
Abstract
Aberrant liquid to solid transition (LST) of tau is a pathological hallmark of several tauopathies, most notably Alzheimer’s disease (AD).
ApoE4 is a major genetic risk factor for AD and has been shown to exacerbatetau pathology, although the underlying mechanismremains unclear.
Herewe investigate whether apoE isoforms can influenceamyloid aggregation of tau occurring via the liquid–liquid phase separation (LLPS) pathway by monitoring individual tau condensates in real time using total internal reflection fluorescence microscopy (TIRFM) and confocal microscopy.
We find that interaction of apoE with tau condensates is dependent on the lipidation status of apoE.
Lipid-free apoE, even at 1:1000 substoichiometric concentrations, arrests growth but promotes ageing of the liquid condensates of tau.
The strong effect of apoE is accompanied by its preferential accumulation inside the condensates, lowering of the surface tension and promoting amyloid nucleation.
Lipidation of apoE2 and apoE3 diminished its amyloid promoting effects very strongly.
However, apoE4 even in the lipidated forms accelerated the liquid to amyloid conversion of the tau condensates considerably.
Furthermore, the amyloidogenic effect of apoE4 is correlated with its higher delipidation tendency compared to apoE2 and apoE3.
Together, our study suggests that lipid-free apoE promotes tau aggregation via dual mechanisms by increasing condensate surface to volume ratio and by facilitating amyloid nucleation possibly at the condensate interfaces.
We hypothesize that enhancing apoE4 lipidation in vivo presents a potential strategy to counteract its pathogenic effects on tau aggregation.
Highlights
All three lipid-free apoE isoforms strongly affect LLPS of tau even at a sub-stoichiometric (1:1000) ratio.
ApoE lowers the surface tension, reduces the size and increases the number of the condensates.
ApoE isoforms accelerate LST of the tau condensates.
Lipidation reduces the effects of apoE, strongly in apoE2 and apoE3 but less so in apoE4.
ApoE4 undergoes spontaneous delipidation faster than apoE3 and apoE2.
Related Results
L᾽«unilinguisme» officiel de Constantinople byzantine (VIIe-XIIe s.)
L᾽«unilinguisme» officiel de Constantinople byzantine (VIIe-XIIe s.)
<p>Νίκος Οικονομίδης</...
North Syrian Mortaria and Other Late Roman Personal and Utility Objects Bearing Inscriptions of Good Luck
North Syrian Mortaria and Other Late Roman Personal and Utility Objects Bearing Inscriptions of Good Luck
<span style="font-size: 11pt; color: black; font-family: 'Times New Roman','serif'">ΠΗΛΙΝΑ ΙΓ&Delta...
Un manoscritto equivocato del copista santo Theophilos († 1548)
Un manoscritto equivocato del copista santo Theophilos († 1548)
<p><font size="3"><span class="A1"><span style="font-family: 'Times New Roman','serif'">ΕΝΑ ΛΑΝ&...
Astrocyte-secreted glypican-4 drives APOE4-dependent tau pathology
Astrocyte-secreted glypican-4 drives APOE4-dependent tau pathology
ABSTRACTThe aggregation of tau proteins into insoluble filaments and the spread of these filaments across brain regions are the major drivers of neurodegeneration in tauopathies, i...
Flavonoids from Stems and Leaves of Scutellaria baicalensis Georgi Regulate
the Brain Tau Hyperphosphorylation at Multiple Sites Induced by
Composited Aβ in Rats
Flavonoids from Stems and Leaves of Scutellaria baicalensis Georgi Regulate
the Brain Tau Hyperphosphorylation at Multiple Sites Induced by
Composited Aβ in Rats
Background:
Neurofibrillary Tangles (NFTs), formed by hyperphosphorylation of Tau
protein in Alzheimer's Disease (AD), arethe main pathomechanisms of neuronal degeneration,
which i...
The Contributions of the Endolysosomal Compartment and Autophagy to APOE ɛ4 Allele-Mediated Increase in Alzheimer’s Disease Risk
The Contributions of the Endolysosomal Compartment and Autophagy to APOE ɛ4 Allele-Mediated Increase in Alzheimer’s Disease Risk
Apolipoprotein E4 (APOE4), although yet-to-be fully understood, increases the risk and lowers the age of onset of Alzheimer’s disease (AD), which is the major cause of dementia amo...
A glycan biomarker predicts cognitive decline in amyloid- and tau-negative patients
A glycan biomarker predicts cognitive decline in amyloid- and tau-negative patients
Abstract
Early detection of Alzheimer’s disease is vital for timely treatment. Existing biomarkers for Alzheimer’s disease reflect amyloid- and tau-related pathology...

